Brian Abrahams' Stock Ratings

RBC Capital Analyst

Brian Abrahams is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

8.88%

Smart Score

67.5%

Overall Average Return Percentile

57th

Number of Ratings

268
Buy NowGet Alert
05/13/2024CRBPBuy Now
Corbus Pharmaceuticals
$47.6361.66% → $77Initiates → OutperformGet Alert
05/07/2024PLRXBuy Now
Pliant Therapeutics
$15.12197.62%$54 → $45MaintainsOutperformGet Alert
05/07/2024VRTXBuy Now
Vertex Pharmaceuticals
$445.87-4.91%$417 → $424MaintainsSector PerformGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$15.0199.87% → $30Initiates → OutperformGet Alert
04/26/2024SAGEBuy Now
Sage Therapeutics
$11.2533.33%$26 → $15MaintainsSector PerformGet Alert
04/26/2024GILDBuy Now
Gilead Sciences
$67.978.87%$76 → $74MaintainsSector PerformGet Alert
04/15/2024MRNSBuy Now
Marinus Pharma
$1.41112.77%$24 → $3DowngradeOutperform → Sector PerformGet Alert
04/11/2024APLTBuy Now
Applied Therapeutics
$4.20185.71% → $12ReiteratesOutperform → OutperformGet Alert
04/09/2024REGNBuy Now
Regeneron Pharmaceuticals
$989.9620.11% → $1189ReiteratesOutperform → OutperformGet Alert
04/03/2024ITCIBuy Now
Intra-Cellular Therapies
$65.3231.66% → $86ReiteratesOutperform → OutperformGet Alert
03/28/2024NMRABuy Now
Neumora Therapeutics
$9.69219.92% → $31ReiteratesOutperform → OutperformGet Alert
03/26/2024APLTBuy Now
Applied Therapeutics
$4.20185.71% → $12Initiates → OutperformGet Alert
03/25/2024INCYBuy Now
Incyte
$57.1913.66% → $65ReiteratesSector Perform → Sector PerformGet Alert
03/25/2024HOOKBuy Now
HOOKIPA Pharma
$0.83501.68% → $5ReiteratesOutperform → OutperformGet Alert
03/12/2024INCYBuy Now
Incyte
$57.1913.66% → $65ReiteratesSector Perform → Sector PerformGet Alert
03/11/2024SAGEBuy Now
Sage Therapeutics
$11.25131.11% → $26ReiteratesSector Perform → Sector PerformGet Alert
03/08/2024PTCTBuy Now
PTC Therapeutics
$39.99-29.98% → $28ReiteratesSector Perform → Sector PerformGet Alert
03/08/2024NMRABuy Now
Neumora Therapeutics
$9.69219.92%$24 → $31MaintainsOutperformGet Alert
03/08/2024MNMDBuy Now
Mind Medicine
$8.12170.94%$15 → $22MaintainsOutperformGet Alert
03/08/2024IGMSBuy Now
IGM Biosciences
$9.29126.05% → $21ReiteratesOutperform → OutperformGet Alert
03/06/2024MRNSBuy Now
Marinus Pharma
$1.411602.13% → $24ReiteratesOutperform → OutperformGet Alert
03/05/2024PLRXBuy Now
Pliant Therapeutics
$15.12257.14%$50 → $54MaintainsOutperformGet Alert
03/05/2024BIIBBuy Now
Biogen
$231.5857.18% → $364ReiteratesOutperform → OutperformGet Alert
03/01/2024XENEBuy Now
Xenon Pharmaceuticals
$40.3536.31%$56 → $55MaintainsOutperformGet Alert
03/01/2024PTCTBuy Now
PTC Therapeutics
$39.99-29.98%$22 → $28MaintainsSector PerformGet Alert
03/01/2024ETNBBuy Now
89bio
$8.9456.6%$15 → $14MaintainsSector PerformGet Alert
02/29/2024SRPTBuy Now
Sarepta Therapeutics
$130.8320%$151 → $157MaintainsOutperformGet Alert
02/29/2024MNMDBuy Now
Mind Medicine
$8.1284.73%$14 → $15MaintainsOutperformGet Alert
02/28/2024PLRXBuy Now
Pliant Therapeutics
$15.12230.69%$53 → $50MaintainsOutperformGet Alert
02/27/2024REGNBuy Now
Regeneron Pharmaceuticals
$989.9619.6%$1096 → $1184MaintainsOutperformGet Alert